Shanghai, China

Chonglan Lin

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: The Innovations of Chonglan Lin

Introduction

Chonglan Lin is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific genetic mutations. His work is characterized by a focus on innovative solutions for cancer treatment.

Latest Patents

Chonglan Lin holds a patent for a substituted heterocyclic fused cyclic compound. This compound is designed to have a selective inhibitory effect on KRAS gene mutations. The patent also covers the preparation method for this compound and its pharmaceutical applications. The compound can exist in various forms, including pharmaceutically acceptable salts, stereoisomers, solvates, or prodrugs. It is intended for use in the preparation of cancer drugs.

Career Highlights

Throughout his career, Chonglan Lin has worked with prominent companies in the biotechnology sector. He has been associated with Genfleet Therapeutics (Shanghai) Inc. and Zhejiang Genfleet Therapeutics Co., Ltd. His expertise in pharmaceutical development has positioned him as a key player in the industry.

Collaborations

Chonglan Lin has collaborated with several professionals in his field, including Fusheng Zhou and Tao Jiang. These collaborations have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Chonglan Lin's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a significant inventor in cancer treatment. His work continues to influence the development of targeted therapies for genetic mutations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…